Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
8
×
life sciences
national blog main
biotech
boston top stories
national top stories
clinical trials
san francisco blog main
abbvie
new york blog main
new york top stories
san francisco top stories
deals
fda
san diego blog main
san diego top stories
startups
allergan
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
investing
medical device
national
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
What
treatment
8
×
medicine
drug
fda
approved
cancer
company
digital
disease
gene
genetic
help
new
abbvie
acorda
aiming
alkermes
alliance
announced
antipsychotic
area
based
bay
benefits
bio
biopsy
biotech
blood
buildout
caveats
centers
clinical
close
closed
commonly
companies
cope
crude
cut
cutting
Language
unset
Current search:
treatment
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?